Metagenomi, Inc. (MGX) Stock Statistics & Valuation Metrics

Metagenomi, Inc. has a market cap or net worth of $63.17M. The enterprise value is $143.06M.

Metagenomi, Inc. has 37,381,496 shares outstanding. The number of shares has decreased by -2.65% in one year.

Metagenomi, Inc.’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -28.35%.

The current PE Ratio of Metagenomi, Inc. is -1.73. Metagenomi, Inc.’s PEG ratio is -0.07.

In the last 12 months, Metagenomi, Inc. had revenue of 52.30M and earned -78.06M in profits. Earnings per share was -2.36.

In the last 12 months, operating cash flow was -102.06M and capital expenditures -2.49M, giving a free cash flow of -104.55M billion.

Metagenomi, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Metagenomi, Inc. upcoming earnings date is Aug 13, 2025, Before Open (Confirmed).

Metagenomi, Inc. as a current ratio of 6.91, with Debt / Equity ratio of -24.95%

In the past 12 months, Metagenomi, Inc. has paid -5.51M in taxes.

Metagenomi, Inc. EV to EBITDA ratio is -1.84, with an EV/FCF ratio of -1.37.

Metagenomi, Inc. has $225.97M in cash and marketable securities with $44.44M in debt, giving a net cash position of -$181.53M billion.

Gross margin is 89.92%, with operating margin of -170.00%, and net profit margin of -149.26%.

The average price target for Metagenomi, Inc. is $10.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy